<VariationArchive VariationID="531731" VariationName="NM_000117.3(EMD):c.135dup (p.Arg46fs)" VariationType="Duplication" Accession="VCV000531731" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-14" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="535110" VariationID="531731">
      <GeneList>
        <Gene Symbol="EMD" FullName="emerin" GeneID="2010" HGNC_ID="HGNC:3331" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154379295" stop="154381523" display_start="154379295" display_stop="154381523" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153607596" stop="153609882" display_start="153607596" display_stop="153609882" Strand="+" />
          </Location>
          <OMIM>300384</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000117.3(EMD):c.135dup (p.Arg46fs)</Name>
      <CanonicalSPDI>NC_000023.11:154379740:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154379740" stop="154379741" display_start="154379740" display_stop="154379741" variantLength="1" positionVCF="154379740" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153608100" stop="153608101" display_start="153608100" display_stop="153608101" variantLength="1" positionVCF="153608100" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>R46fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153608102dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153608102dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154379742dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154379742dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008677.1" sequenceAccession="NG_008677" sequenceVersion="1" change="g.10307dup">
            <Expression>NG_008677.1:g.10307dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000117.3" sequenceAccession="NM_000117" sequenceVersion="3" change="c.135dup" MANESelect="true">
            <Expression>NM_000117.3:c.135dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000108.1" sequenceAccession="NP_000108" sequenceVersion="1" change="p.Arg46fs">
            <Expression>NP_000108.1:p.Arg46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_745" sequenceAccession="LRG_745">
            <Expression>LRG_745:g.10307dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000117.2" sequenceAccession="NM_000117" sequenceVersion="2" change="c.135dupG">
            <Expression>NM_000117.2:c.135dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658799911" DB="ClinGen" />
        <XRef Type="rs" ID="1557182301" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000117.3(EMD):c.135dup (p.Arg46fs) AND X-linked Emery-Dreifuss muscular dystrophy" Accession="RCV000638214" Version="7">
        <ClassifiedConditionList TraitSetID="6541">
          <ClassifiedCondition DB="MedGen" ID="C0751337">X-linked Emery-Dreifuss muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-07-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000117.3(EMD):c.135dup (p.Arg46fs) AND Emery-Dreifuss muscular dystrophy" Accession="RCV001553580" Version="2">
        <ClassifiedConditionList TraitSetID="9433">
          <ClassifiedCondition DB="MedGen" ID="C0410189">Emery-Dreifuss muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-29" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-29" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24365856</ID>
        </Citation>
        <DescriptionHistory Dated="2021-08-07">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6541" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15903" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, tardive Emery-Dreifuss type, with contractures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked Emery-Dreifuss muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0010680" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2102" />
                <XRef ID="2102" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure along with variable cardiac rhythm disturbances. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and intrafamilial variability. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade and respiratory function may be impaired in some individuals.</Attribute>
                <XRef ID="NBK1436" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301609</ID>
                <ID Source="BookShelf">NBK1436</ID>
              </Citation>
              <XRef ID="261" DB="Orphanet" />
              <XRef ID="98863" DB="Orphanet" />
              <XRef ID="C0751337" DB="MedGen" />
              <XRef ID="MONDO:0010680" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9433" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9490" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Emery-Dreifuss muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0016830" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS310300" DB="OMIM" />
                <XRef ID="111508004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy, tardive, Dreifuss-Emery type, with contractures</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Scapuloperoneal syndrome, X-linked (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Humeroperoneal neuromuscular disease, (formerly)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EDMD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure along with variable cardiac rhythm disturbances. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and intrafamilial variability. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade and respiratory function may be impaired in some individuals.</Attribute>
                <XRef ID="NBK1436" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6329" />
                <XRef ID="6329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301609</ID>
                <ID Source="BookShelf">NBK1436</ID>
              </Citation>
              <Citation Type="general" Abbrev="AAN, 2017">
                <ID Source="PubMed">25313375</ID>
                <ID Source="pmc">4206155</ID>
              </Citation>
              <XRef ID="261" DB="Orphanet" />
              <XRef ID="C0410189" DB="MedGen" />
              <XRef ID="MONDO:0016830" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS310300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3484039" SubmissionDate="2021-08-05" DateLastUpdated="2021-08-07" DateCreated="2021-08-07">
        <ClinVarSubmissionID localKey="NM_000117.2:c.135dupG|MedGen:C0410189" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001774481" DateUpdated="2021-08-07" DateCreated="2021-08-07" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Variant summary: EMD c.135dupG (p.Arg46AlafsX15) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 172063 control chromosomes (gnomAD). To our knowledge, no occurrence of c.135dupG in individuals affected with Emery-Dreifuss Muscular Dystrophy and no experimental evidence demonstrating its impact on protein function have been reported. One ClinVar submitter (evaluation after 2014) cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000117.2:c.135dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0410189" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10156071</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1469432" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="3466010|MedGen:C0751337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000759700" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24365856</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg46Alafs*15) in the EMD gene. It is expected to result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with EMD-related disease. Loss-of-function variants in EMD are known to be pathogenic (PMID: 24365856). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EMD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.153608100_153608101insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751337" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1469432" TraitType="Disease" MappingType="XRef" MappingValue="C0751337" MappingRef="MedGen">
        <MedGen CUI="C0751337" Name="X-linked Emery-Dreifuss muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3484039" TraitType="Disease" MappingType="XRef" MappingValue="C0410189" MappingRef="MedGen">
        <MedGen CUI="C0410189" Name="Emery-Dreifuss muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

